Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy

Journal of Diabetes

Volumn 6, Issue 2, 2014, Pages 167-175

  Rodríguez Carrizalez, Adolfo Daniel ^a   Castellanos González, José Alberto ^b   Martínez Romero, Esaú César ^b   Miller Arrevillaga, Guillermo ^b   Villa Hernández, David ^b   Hernández Godínez, Pedro Pablo ^b   Ortiz, Genaro Gabriel ^c   Pacheco Moisés, Fermín Paul ^a   Cardona Muñoz, Ernesto Germán ^a   Miranda Díaz, Alejandra Guillermina ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b Departament of Ophthalmology   (Mexico)

^c Institute for Social Security   (Mexico)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Membrane fluidity; Nitrosative stress; Oxidative

Indexed keywords

DIABETES MELLITUS; DIABETIC RETINOPATHY; MEMBRANE FLUIDITY; NITROSATIVE STRESS; OXIDATIVE STRESS;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; ANTIOXIDANTS; CATALASE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ERYTHROCYTES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYDROLYSIS; LIPID PEROXIDATION; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; MULTIVARIATE ANALYSIS; NITRIC OXIDE; OXIDANTS; PROTON-TRANSLOCATING ATPASES;

EID: 84895071252     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12076     Document Type: Article

References (30)

1. Ghafour IM, Allan D, Foulds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol. 1983; 67: 209-213.
2. Claramunt JL. Diabetic retinopathy. Rev Med Clin Condes. 2009; 20: 670-679.
3. Center for Accredited Healthcare Education. Medscape: Clinical management of diabetic retinopathy. 2005. Available from: http://www.medscape.org/viewprogram/4219 (accessed 3 January 2011).
4. Ali MK, McKeever Bullard K, Imperatore G, Barker L, Gregg EW, Centers for Disease Control and Prevention (CDC). Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes: National Health and Nutrition Examination Survey, United States, 2007-2010. MMWR Morb Mortal Wkly Rep. 2012; 61: 32-37.
5. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev. 2002; 82: 47-95.
6. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001; 53: 135-159.
7. Erusalimsky JD, Moncada S. Nitric oxide and mitocondrial signaling from physiology to pathophysiology. Arterioscler Thromb Vasc Biol. 2007; 27: 2524-2531.
8. Pitocco D, Zaccardi F, Di Stasio E etal. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud. 2010; 7: 15-25.
9. Izumi N, Nagaoka T, Mori F, Sato E, Takahashi A, Yoshida A. Relation between plasma nitric oxide levels and diabetic retinopathy. Jpn J Ophthalmol. 2006; 50: 465-468.
10. Roy S, Trudeau K, Roy S, Tien T, Barrette KF. Mitochondrial dysfunction and endoplasmic reticulum stress in diabetic retinopathy: A mechanistic insight for high glucose-induced retinal cell death. Curr Clin Pharmacol. 2011; 4: 51-61.
11. Ghasemi A, Hedayati M, Biabani H. Protein precipitation methods evaluated for determination of serum nitric oxide end products by the Griess assay. J Med Sci Res. 2007; 2: 29-32.
12. Ortiz GG, Pacheco-Moisés F, El Hafidi M etal. Detection of membrane fluidity in submitochondrial particles of platelets and erythrocyte membranes from Mexican patients with Alzheimer disease by intramolecular excimer formation of 1, 3 dipyrenylpropane. Dis Markers. 2008; 24: 151-156.
13. Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010; 3: 153-156.
14. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest. 1988; 82: 735-737.
15. Mandarino LJ. Current hypotheses for the biochemical basis of diabetic retinopathy. Diabetes Care. 1992; 15: 1892-1901.
16. Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes. Diabetes Care. 1992; 15: 256-260.
17. Nishikawa T, Edelstein D, Du XL etal. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404: 787-790.
18. 2 and genistein differentially modulate protein tyrosine phosphorylation, endothelial morphology, and monolayer barrier function. Biochem Biophys Res Commun. 1998; 249: 461-466.
19. Huang Q, Sheibani N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Cell Physiol. 2008; 295: C1647-1657.
20. Mancino R, Di Pierro D, Varesi C etal. Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis. 2011; 17: 1298-1304.
21. Lin KC, Tsai ST, Lin HY, Chou P. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. J Rheumatol. 2004; 31: 1159-1165.
22. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy. 2000; 101: 541-551.
23. Meisinger C, Döring A, Stöckl D, Thorand B, Kowall B, Rathmann W. Uric acid is more strongly associated with impaired glucose regulation in women than in men from the general population: The KORA F4-Study. PLoS ONE. 2012; 7: e37180.
24. Kurtul N, Bakan E, Aksoy H, Baykal O. Leukocyte lipid peroxidation, superoxide dismutase and catalase activities of type 2 diabetic patients with retinopathy. Acta Medica. 2005; 48: 35-38.
25. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 2000; 26: 387-392.
26. Rema M, Mohan V, Bhaskar A, Shanmugasundaram KR. Does oxidant stress play a role in diabetic retinopathy? Indian J Ophthalmol. 1995; 43: 17-21.
27. Trudeau K, Molina AJ, Roy S. High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes. Invest Ophthalmol Vis Sci. 2011; 52: 8657-8664.
28. Santos JM, Tewari S, Goldberg AF, Kowluru RA. Mitochondrial biogenesis and the development of diabetic retinopathy. Free Radic Biol Med. 2011; 51: 1849-1860.
29. Klein R, Klein BEK. Diabetic eye disease. Lancet. 1997; 350: 197-204.
30. Martínez-Cano E, Ortiz-Genaro G, Pacheco-Moisés F, Macías-Islas MA, Sánchez-Nieto S, Rosales-Corral SA. Functional disorders of FOF1-ATPase in submitochondrial particles obtained from platelets of patients with a diagnosis of probable Alzheimer's Disease. Rev Neurol. 2005; 40: 81-85.